Events Search and Views Navigation
Ongoing
SCALEUP Maryland
The SCALEUP Maryland Program, presented by bwtech@UMBC in partnership with TCV Growth Partners, is a virtual, weekly, four-month program designed for C-level leaders seeking to strengthen and grow their operations and teams. The program focuses on developing and implementing a strategic plan to enhance business performance, covering topics based on the five key elements of scaling a company: sales and marketing, finance, operations, human capital, and leadership. Each session involves facilitators and peer teams who provide guidance, challenges, and support...
Find out more »8:00 am
Advancing Medical Applications of Cancer Nanotechnology
The Nanotechnology Characterization Laboratory (NCL) has made significant strides in advancing cancer nanotechnology over the past two decades. Established by the National Cancer Institute in 2004 in collaboration with the US Food and Drug Administration and the National Institute of Standards and Technology, NCL has played a crucial role in bridging the gap between nanotechnology innovations and their clinical applications in oncology. To celebrate two successful decades of NCL’s contributions to advancing the field of cancer nanotechnology, this symposium brings together NCL...
Find out more »Advancing Medical Applications of Cancer Nanotechnology
The Nanotechnology Characterization Laboratory (NCL) has made significant strides in advancing cancer nanotechnology over the past two decades. Established by the National Cancer Institute in 2004 in collaboration with the US Food and Drug Administration and the National Institute of Standards and Technology, NCL has played a crucial role in bridging the gap between nanotechnology innovations and their clinical applications in oncology. To celebrate two successful decades of NCL’s contributions to advancing the field of cancer nanotechnology, this symposium brings together NCL...
Find out more »Advancing Medical Applications of Cancer Nanotechnology
The Nanotechnology Characterization Laboratory (NCL) has made significant strides in advancing cancer nanotechnology over the past two decades. Established by the National Cancer Institute in 2004 in collaboration with the US Food and Drug Administration and the National Institute of Standards and Technology, NCL has played a crucial role in bridging the gap between nanotechnology innovations and their clinical applications in oncology. To celebrate two successful decades of NCL’s contributions to advancing the field of cancer nanotechnology, this symposium brings together NCL...
Find out more »